ASRS
APLS

Arizona State Retirement System’s Apellis Pharmaceuticals APLS Stock Holding History

Arizona State Retirement System’s Portfolio APLS Stock Details APLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$837K Sell
20,813
-197
-0.9% -$4.25K ﹤0.01% 1191
2025
Q4 		$528K Sell
21,010
-1,288
-6% -$30.2K ﹤0.01% 1444
2025
Q3 		$505K Buy
22,298
+315
+1% +$7.35K ﹤0.01% 1509
2025
Q2 		$381K Buy
21,983
+2,444
+13% +$45.2K ﹤0.01% 1594
2025
Q1 		$427K Sell
19,539
-1,665
-8% -$46K ﹤0.01% 1499
2024
Q4 		$677K Sell
21,204
-1,512
-7% -$45.5K ﹤0.01% 1336
2024
Q3 		$655K Buy
22,716
+703
+3% +$26K ﹤0.01% 1343
2024
Q2 		$844K Buy
22,013
+2,473
+13% +$112K 0.01% 1119
2024
Q1 		$1.15M Sell
19,540
-3,500
-15% -$223K 0.01% 981
2023
Q4 		$1.38M Sell
23,040
-171
-0.7% -$8.67K 0.01% 872
2023
Q3 		$883K Buy
23,211
+541
+2% +$23.8K 0.01% 1064
2023
Q2 		$2.07M Sell
22,670
-2,961
-12% -$255K 0.02% 656
2023
Q1 		$1.69M Buy
25,631
+830
+3% +$47.9K 0.02% 734
2022
Q4 		$1.28M Buy
24,801
+1,643
+7% +$87.1K 0.01% 849
2022
Q3 		$1.58M Buy
23,158
+1,970
+9% +$117K 0.02% 699
2022
Q2 		$958K Buy
21,188
+481
+2% +$21.9K 0.01% 987
2022
Q1 		$1.05M Buy
20,707
+90
+0.4% +$3.97K 0.01% 1034
2021
Q4 		$975K Buy
20,617
+4,172
+25% +$164K 0.01% 1114
2021
Q3 		$542K Buy
16,445
+59
+0.4% +$3.31K ﹤0.01% 1496
2021
Q2 		$1.04M Sell
16,386
-149
-0.9% -$7.69K 0.01% 1093
2021
Q1 		$710K Buy
16,535
+91
+0.6% +$4.31K 0.01% 1338
2020
Q4 		$941K Sell
16,444
-1,783
-10% -$75.4K 0.01% 1082
2020
Q3 		$550K Buy
18,227
+4,627
+34% +$138K 0.01% 1250
2020
Q2 		$444K Sell
13,600
-183
-1% -$5.88K 0.01% 1191
2020
Q1 		$369K Buy
+13,783
New +$489K 0.01% 1162

Other funds holding APLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Arizona State Retirement System's APLS Position: Q1 2026 in Review

Arizona State Retirement System reduced its Apellis Pharmaceuticals (APLS) stake by 0.94% in Q1 2026, selling an estimated $4.25K and leaving 20,813 shares worth $837K. The position accounts for ﹤0.01% of the portfolio, ranked #1191.

Arizona State Retirement System first reported a position in APLS in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.07M in Q2 2023. 323 funds tracked by Wall St. Rank hold APLS as of Q1 2026.

  • Arizona State Retirement System held 20,813 shares of Apellis Pharmaceuticals worth $837K as of Q1 2026.
  • Arizona State Retirement System sold 197 Apellis Pharmaceuticals shares in Q1 2026, an estimated $4.25K.
  • Apellis Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1191 holding.
  • Arizona State Retirement System first reported a position in Apellis Pharmaceuticals in Q1 2020 and has held it in 25 quarters since.
  • Arizona State Retirement System's Apellis Pharmaceuticals position peaked at $2.07M in Q2 2023.
  • 323 funds tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.